COLLEGIUM PHARMACEUTICAL, INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
VA
Business Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
Mailing Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
Phone
781-713-3699
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$69.19M
Net Income
$1.43B
Total Liabilities
$301.68M
Stockholders' Equity
$238.95M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| 10-K Annual financial report | February 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
Material Events
8-K
Acquisition
March 19, 2026
High Impact
- COLLEGIUM acquires U.S. rights to AZSTARYS®, an ADHD drug, for $650 million cash plus potential $135 million.
- Diversifies COLLEGIUM beyond pain medications into the large, growing ADHD market (over $10 billion yearly).
Insider Trading
STRONG SELL
3 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.